Dr. Jeffrey R. Jay, M.D.

Great Point Partners as of March 31, 2017

Portfolio Holdings for Great Point Partners

Great Point Partners holds 34 positions in its portfolio as reported in the March 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Adamas Pharmaceuticals 9.0 $46M 2.6M 17.50
Sage Therapeutics (SAGE) 8.5 $43M 602k 71.07
Concert Pharmaceuticals I equity 7.5 $38M 2.2M 17.06
Synergy Pharmaceuticals 6.7 $34M 7.2M 4.66
Vanda Pharmaceuticals (VNDA) 6.2 $31M 2.2M 14.00
Rigel Pharmaceuticals (RIGL) 6.0 $30M 9.1M 3.31
Zogenix 5.3 $27M 2.4M 10.85
Ignyta 5.2 $26M 3.1M 8.60
Therapeuticsmd 5.0 $25M 3.5M 7.20
Neurocrine Biosciences (NBIX) 4.8 $24M 560k 43.30
Foamix Pharmaceuticals 3.6 $18M 3.7M 4.95
Dbv Technologies S A (DBVT) 3.4 $17M 486k 35.22
Avexis 3.0 $15M 200k 76.03
Ptc Therapeutics I (PTCT) 2.9 $15M 1.5M 9.84
Alnylam Pharmaceuticals (ALNY) 2.7 $13M 262k 51.23
Global Blood Therapeutics In 2.2 $11M 300k 36.85
Acorda Therapeutics 2.1 $11M 513k 21.00
Paratek Pharmaceuticals 2.1 $10M 540k 19.25
Neuroderm Ltd F 1.7 $8.4M 315k 26.55
Bovie Medical Corporation 1.6 $8.2M 3.1M 2.67
Acceleron Pharma 1.6 $7.9M 300k 26.47
Aurinia Pharmaceuticals (AUPH) 1.5 $7.3M 1.0M 7.34
Sunesis Pharmaceuticals Inc Ne 1.2 $6.3M 1.5M 4.10
Five Prime Therapeutics 1.1 $5.6M 155k 36.15
Blueprint Medicines (BPMC) 1.0 $4.9M 122k 39.99
Myovant Sciences 0.9 $4.8M 408k 11.74
Connecture 0.9 $4.4M 4.1M 1.07
Jazz Pharmaceuticals (JAZZ) 0.7 $3.6M 25k 145.12
Aimmune Therapeutics 0.5 $2.7M 123k 21.73
Radius Health 0.4 $1.9M 50k 38.66
Cascadian Therapeutics 0.3 $1.6M 378k 4.14
Trevena 0.2 $1.2M 338k 3.67
Aradigm 0.2 $988k 637k 1.55
Streamline Health Solutions (STRM) 0.0 $155k 152k 1.02